The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community. Founded in 1991, the cancer center became a National Cancer Institute-designated comprehensive cancer center in 1997, one of only 42 institutions in the United States and two in Minnesota to hold that designation.
More than 500 faculty and staff are members of the Masonic Cancer Center. It is home to some of the world's top cancer researchers in bone marrow transplantation, breast cancer, bone cancer, cancer genetics, tobacco research, immunology, new therapies development, pediatric oncology, chemoprevention, and epidemiology.
- Research is organized into seven programs that focus on specific themes.
- The Cancer Information Line 1-888-CANCER MN (1-888-226-2376) is available for residents of Minnesota, Iowa, North Dakota, South Dakota, and Wisconsin.
- Through clinical trials, researchers learn which approaches are more effective than others.
- Program meetings, seminars, and other interdisciplinary meetings at the Masonic Cancer Center brings together experts from different fields to address the problem of cancer.
- Members can apply for internal grant mechanisms available through the Masonic Cancer Center Internal Grants Program which is offered on an annual basis. The overall goal of this program is to foster the development of and provide support for novel research ideas that focus on a problem in cancer. In turn, the Cancer Center expects that these internal awards will lead to nationally peer reviewed funding.
News and Events
December 2 conference to focus on human subjects research
The University of Minnesota will host a national conference - "Research with Human Participants: The National Debate"s - on Tuesday, December 2, 2015, 8:30 a.m.-5 p.m.; in Coffman Memorial Union on the University of Minnesota East Bank campus. Researchers, policymakers, bioethicists, patient advocates, and other stakeholders will explore research oversight, informed consent when research participants have diminished or fluctuating capacity to consent, community roles, conflicts of interest and industry sponsorship, and research with vulnerable individuals. This conference will be an opportunity to explore these issues in depth and from multiple points of view. Learn more and view the agenda and list of speakers.